Additional file 1 of The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

Additional file 1 of The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

Additional file 1: The Flow Cytometric assay results of per-patient levels of ROS at baseline (B) and week 26 (A).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gohari, Sepehr, Reshadmanesh, Tara, Khodabandehloo, Hadi, Karbalaee-Hasani, Amir, Ahangar, Hassan, Arsang-Jang, Shahram, Ismail-Beigi, Faramarz, Dadashi, Mohsen, Ghanbari, Samin, Taheri, Homa, Fathi, Mojtaba, Muhammadi, Muhammad Javad, Mahmoodian, Reyhaneh, Asgari, Atieh, Tayaranian, Mohammadreza, Moharrami, Mehdi, Mahjani, Mahsa, Ghobadian, Bijan, Chiti, Hossein, Gohari, Sheida
Format: Dataset
Sprache:eng
Schlagworte:
Cancer
Cell Biology
Chemical Sciences not elsewhere classified
Developmental Biology
FOS: Biological sciences
FOS: Chemical sciences
FOS: Clinical medicine
FOS: Health sciences
Immunology
Infectious Diseases
Medicine
Microbiology
Physiology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 1: The Flow Cytometric assay results of per-patient levels of ROS at baseline (B) and week 26 (A).
DOI:10.6084/m9.figshare.21582278